Adjunctive Donepezil Therapy and Genetic Risk Factors of Cognitive Dysfunction in Brain Tumor Survivors
Phase of Trial: Phase I
Latest Information Update: 27 Jan 2016
At a glance
- Drugs Donepezil (Primary)
- Indications Brain cancer; Cognition disorders
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 13 Jan 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Dec 2015 Planned primary completion date changed from 1 Oct 2015 to 1 Oct 2016 as reported by ClinicalTrials.gov record.